Filter Results:
- Full text PDF available (4)
Publication Year
2014
2019
- This year (8)
- Last 5 years (21)
- Last 10 years (21)
Publication Type
Co-author
Journals and Conferences
Learn More
- Lisa Menegazzo, Stefano Ciciliot, +7 authors Gian Paolo Fadini
- Acta Diabetologica
- 2014
The role of neutrophils in diabetes and its complications is unclear. Upon challenge with microbes and inflammatory triggers, neutrophils release enzymes and nuclear material, forming neutrophils… (More)
- Gian Paolo Fadini, Benedetta Maria Bonora, +6 authors Angelo Avogaro
- The Journal of clinical endocrinology and…
- 2016
CONTEXT
Circulating cells, including endothelial progenitor cells (EPCs) and monocyte subtypes, are involved in diabetic complications. Modulation of these cells may mediate additional benefits of… (More)
- Gian Paolo Fadini, Benedetta Maria Bonora, Angelo Avogaro
- Diabetologia
- 2017
Sodium-glucose co-transporter-2 inhibitors (SGLT2i) are indicated for the treatment of type 2 diabetes and may also improve glucose control in type 1 diabetes. In 2015, regulatory agencies warned… (More)
- Lisa Menegazzo, Valentina Scattolini, +8 authors Gian Paolo Fadini
- Acta Diabetologica
- 2018
Diabetes is associated with an excess release of neutrophil extracellular traps (NETs) and an enhanced NETosis, a neutrophil cell death programme instrumental to anti-microbial defences, but also… (More)
- Benedetta Maria Bonora, Alberto Maran, Stefano Ciciliot, Angelo Avogaro, Gian Paolo Fadini
- Journal of endocrinological investigation
- 2016
PURPOSE
Continuous glucose monitoring (CGM) is being increasingly used in clinical practice. The flash glucose monitoring (FGM) and CGM are different systems of interstitial glucose recording. We… (More)
- Gian Paolo Fadini, Mauro Rigato, Roberta Cappellari, Benedetta Maria Bonora, Angelo Avogaro
- Diabetes care
- 2017
OBJECTIVE
Cardiovascular risk varies substantially in the population with diabetes, and biomarkers can improve risk stratification. Circulating stem cells predict future cardiovascular events and… (More)
- Roberta Cappellari, Marianna D'Anna, +4 authors Gian Paolo Fadini
- Atherosclerosis
- 2017
BACKGROUND AND AIMS
Distribution of monocyte subsets has been shown to predict cardiovascular outcomes. However, monocytes form a continuum and categorization into discrete subsets may be an… (More)
- Silvia Galasso, Andrea Facchinetti, +7 authors Daniela Bruttomesso
- Nutrition, metabolism, and cardiovascular…
- 2016
BACKGROUND AND AIMS
Degludec is an ultralong-acting insulin analogue with a flat and reproducible pharmacodynamic profile. As some patients with type 1 diabetes (T1D) fail to achieve 24-h coverage… (More)
- Gian Paolo Fadini, Benedetta Maria Bonora, +5 authors Angelo Avogaro
- Cardiovascular diabetology
- 2017
BACKGROUND
Sodium-glucose co-transporter-2 inhibitors (SGLT2i) reduce glucose levels, body weight, and blood pressure, possibly resulting in cardiovascular protection. In phase III trials, SGLT2i… (More)
- Benedetta Maria Bonora, Angelo Avogaro, Gian Paolo Fadini
- Diabetes, obesity & metabolism
- 2018
Sodium-glucose cotransporter-2 inhibitors (SGLT2is) are increasingly used for the treatment of type 2 diabetes (T2D) and can improve glucose control also in type 1 diabetes (T1D). In May 2015,… (More)